HA
TRIB

Heartland Advisors’s Trinity Biotech TRIB Stock Holding History

Heartland Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-98,479
Closed -$995K – 228
2020
Q3 		$995K Sell
98,479
-75,521
-43% -$874K 0.09% 194
2020
Q2 		$1.9M Sell
174,000
-3,060
-2% -$23.3K 0.17% 159
2020
Q1 		$974K Buy
177,060
+45,305
+34% +$237K 0.1% 170
2019
Q4 		$681K Buy
131,755
+18,822
+17% +$89.5K 0.05% 175
2019
Q3 		$683K Sell
112,933
-64,007
-36% -$556K 0.05% 173
2019
Q2 		$1.46M Hold
176,940
– – 0.11% 167
2019
Q1 		$2.52M Hold
176,940
– – 0.19% 150
2018
Q4 		$2.03M Buy
176,940
+18,449
+12% +$285K 0.17% 156
2018
Q3 		$3.17M Sell
158,491
-14,589
-8% -$317K 0.21% 155
2018
Q2 		$4.33M Sell
173,080
-62,084
-26% -$1.49M 0.29% 140
2018
Q1 		$6.05M Sell
235,164
-34,066
-13% -$929K 0.41% 111
2017
Q4 		$6.87M Sell
269,230
-12,380
-4% -$319K 0.44% 102
2017
Q3 		$7.9M Sell
281,610
-31,500
-10% -$879K 0.51% 96
2017
Q2 		$9.39M Buy
313,110
+4,000
+1% +$113K 0.6% 76
2017
Q1 		$9.21M Buy
309,110
+2,360
+0.8% +$73.8K 0.56% 76
2016
Q4 		$10.6M Buy
306,750
+52,863
+21% +$1.82M 0.59% 75
2016
Q3 		$16.8M Buy
253,887
+3,167
+1% +$197K 0.96% 22
2016
Q2 		$14.2M Sell
250,720
-7,282
-3% -$410K 0.8% 41
2016
Q1 		$15M Buy
258,002
+7,532
+3% +$400K 0.79% 41
2015
Q4 		$14.7M Buy
250,470
+9,726
+4% +$574K 0.59% 58
2015
Q3 		$13.8M Buy
240,744
+2,890
+1% +$233K 0.5% 69
2015
Q2 		$21.5M Sell
237,854
-80
-0% -$6.93K 0.6% 50
2015
Q1 		$22.9M Hold
237,934
– – 0.57% 56
2014
Q4 		$20.8M Sell
237,934
-2,630
-1% -$227K 0.41% 85
2014
Q3 		$22M Sell
240,564
-413
-0.2% -$44.7K 0.43% 90
2014
Q2 		$27.7M Sell
240,977
-2,399
-1% -$284K 0.48% 74
2014
Q1 		$29.5M Sell
243,376
-1,800
-0.7% -$236K 0.52% 66
2013
Q4 		$30.8M Sell
245,176
-4,897
-2% -$588K 0.54% 66
2013
Q3 		$27.2M Sell
250,073
-63,867
-20% -$6.23M 0.5% 72
2013
Q2 		$26.4M Buy
+313,940
New +$26M 0.49% 83

Other funds holding TRIB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Heartland Advisors's TRIB Position: Q4 2020 in Review

Heartland Advisors sold out of Trinity Biotech (TRIB) in Q4 2020, closing a stake of 98,479 shares — an estimated $995K sold.

Heartland Advisors first reported a position in TRIB in Q2 2013 and held it in 30 quarters. The position peaked at $30.8M in Q4 2013. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2020.

  • Heartland Advisors reported no remaining Trinity Biotech position as of Q4 2020 after selling out during the quarter.
  • Heartland Advisors sold 98,479 Trinity Biotech shares in Q4 2020, an estimated $995K.
  • Heartland Advisors first reported a position in Trinity Biotech in Q2 2013 and held it in 30 quarters.
  • Heartland Advisors's Trinity Biotech position peaked at $30.8M in Q4 2013.
  • 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2020.

Based on Heartland Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.